help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MAGHNI, K.
Right arrow Articles by MARTIN, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAGHNI, K.
Right arrow Articles by MARTIN, J. G.

Am. J. Respir. Crit. Care Med., Volume 162, Number 3, September 2000, 1068-1074

Dichotomy between Neurokinin Receptor Actions in Modulating Allergic Airway Responses in an Animal Model of Helper T Cell Type 2 Cytokine-associated Inflammation

KARIM MAGHNI, RAME TAHA, WAQQAS AFIF, QUTAYBA HAMID, and JAMES G. MARTIN

Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada

Neurokinins (NKs), which include substance P (SP) and neurokinin A (NKA), act through NK-1 and NK-2 receptors. There is considerable evidence of interaction between the neurogenic and the immune systems, and NKs are candidates for mediating such interactions. We hypothesized that selective inhibition of pulmonary NK-1 or NK-2 receptors may modulate immune responses so as to prevent the development of allergic airway responses in the atopic BN rat sensitized to ovalbumin (OA). To address this hypothesis, we have validated our animal model by showing that NK-1 and NK-2 receptors are expressed in the lungs, and that SP is released in the airways after allergen challenge. The selective NK-1 (CP-99,994) or NK-2 (SR-48968) antagonists before allergen challenge failed to reduce the allergic early airway responses. In contrast, both neurokinin antagonists decreased allergen-induced late airway responses in OA-challenged animals. However, only the NK-2 antagonist decreased the eosinophil numbers in the bronchoalveolar lavage (BAL). Likewise, the NK-2, but not NK-1, antagonist decreased both Th1 (INF-gamma ) and Th2 (IL-4 and -5) cytokine expression in BAL cells by in situ hybridization. These results provide initial in vivo evidence linking neurokinins to the regulation of cytokine expression in cells without discrimination as to their phenotype. We conclude that there is a dichotomy between NK receptors in the modulation of the allergic airway inflammation, which has important implications for future therapeutic strategies for asthma using the NK antagonists.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. R. Gil, N. B. Zitouni, E. Azoulay, K. Maghni, and A.-M. Lauzon
Smooth muscle myosin isoform expression and LC20 phosphorylation in innate rat airway hyperresponsiveness
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L932 - L940.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. S. Davis, J. R. Malayer, L. Vandeventer, C. M. Royer, E. C. McKenzie, and K. K. Williamson
Cold weather exercise and airway cytokine expression
J Appl Physiol, June 1, 2005; 98(6): 2132 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S.-Y. Eum, K. Maghni, B. Tolloczko, D. H. Eidelman, and J. G. Martin
IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L576 - L584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. A. Tuck, K. Maghni, A. Poirier, G. J. Babu, M. Periasamy, J. H. T. Bates, R. Leguillette, and A.-M. Lauzon
Time Course of Airway Mechanics of the (+)Insert Myosin Isoform Knockout Mouse
Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 326 - 332.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. F. JOOS, K. O. DE SWERT, V. SCHELFHOUT, and R. A. PAUWELS
The Role of Neural Inflammation in Asthma and Chronic Obstructive Pulmonary Disease
Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 218 - 230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. N. Freed, S. McCulloch, T. Meyers, and R. Suzuki
Neurokinins Modulate Hyperventilation-induced Bronchoconstriction in Canine Peripheral Airways
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1102 - 1108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Maghni, M.-C. Michoud, M. Alles, A. Rubin, V. Govindaraju, C. Meloche, and J. G. Martin
Airway Smooth Muscle Cells Express Functional Neurokinin-1 Receptors and the Nerve-Derived Preprotachykinin-A Gene: Regulation by Passive Sensitization
Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M.-C. Michoud, G. Napolitano, K. Maghni, V. Govindaraju, A. Cogo, and J. G. Martin
Effects of Extracellular Triphosphate Nucleotides and Nucleosides on Airway Smooth Muscle Cell Proliferation
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. L. J. Van Rensen, P. S. Hiemstra, K. F. Rabe, and P. J. Sterk
Assessment of Microvascular Leakage via Sputum Induction: The Role of Substance P and Neurokinin A in Patients with Asthma
Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1275 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society